Surveillance for antimicrobial resistance in enterococci

New Zealand Medical Journal

Volumn 110, Issue 1047, 1997, Pages 251-253

  Taylor, Susan L ^a,e   Pottumarthy, Sudha ^b   Wong, Christopher G S ^c   Bremner, David A ^a   Morris, Arthur J ^d  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b Gn Ln and Natl Women's Hospitals ^*  (New Zealand)

^c MIDDLEMORE HOSPITAL   (New Zealand)

^d NATIONAL WOMEN S HOSPITAL   (New Zealand)

^e STARSHIP CHILDREN S HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; CROSS INFECTION; DRUG EFFECT; ENTEROCOCCUS; FECES; HOSPITAL; HUMAN; INFECTION CONTROL; ISOLATION AND PURIFICATION; MICROBIOLOGY; NEW ZEALAND; PENICILLIN RESISTANCE; PROSPECTIVE STUDY;

CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS; FECES; HOSPITALS; HUMANS; INFECTION CONTROL; NEW ZEALAND; PENICILLIN RESISTANCE; PROSPECTIVE STUDIES;

EID: 0031564791     PISSN: 00288446     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Woodford N, Johnson AP, Morrison D, Speller DCE. Current perspectives on glycopeptide resistance. Clin Microbiol Rev 1995; 8: 585-615.
2. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988; 319: 157-61.
3. Centers for Disease Control and Prevention. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 1995; 44(No. RR-12): 1-13.
4. Facklam RR, Sahm DF. Enterococcus p. 308-14. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology, 6th ed. Washington: American Society for Microbiology, 1995.
5. Facklam RR, Collins MD. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol 1989; 27: 731-4.
6. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 3rd ed. Villanova, PA: National Committee for Clinical Laboratory Standards, 1993; publication M7-A3.
7. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; Sixth Informational Supplement. Villanova, PA: National Committee for Clinical Laboratory Standards, 1995; publication M100-S6.
8. Murray BE. The life and times of the enterococcus. Clin Microbiol Rev 1990; 3: 46-65.
9. Zervos MJ, Dembinski S, Mikesell TS, Schaberg DR. High level resistance to gentamicin in Streptococcus faecalis: risk factors and evidence for exogenous acquisition of infection. J Infect Dis 1986; 153: 1075-83.
10. Rhinehart E, Smith NE, Wennersten C, et al. Rapid dissemination of β-lactamase producing aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward. N Engl J Med 1990; 323: 1814-8
11. Chenoweth CE, Schaberg DR. Enterococcus species p. 334-45. In: Mayhall CG, ed. Hospital epidemiology and infection control. Baltimore: Williams and Wilkins, 1996.
12. Centers for Disease Control. Nosocomial enterococci resistant to vancomycin: United states, 1989-1993: National Nosocomial Infection Surveillance. MMWR 1993; 42: 597-9.
13. Toala P, McDonald A, Wilcox C, Finland M. Susceptibility of group D Streptococcus (Enterococcus) to 21 antibiotics in vitro, with special reference to species differences. Am J Med Sci 1969; 258: 416-30.
14. Murray BE, Mederski-Samoraj B. Transferable, β-lactamase: a new mechanism for in vitro penicillin resistance in Streptococcus faecalis. J Clin Invest 1983; 72: 1168-71.
15. Murray BE, An FY, Clewell DB. Plasmids and pheromone response of the β-lactamase producer Streptococcus (Enterococcus) faecalis HH22. Antimicrob Agents Chemother 1988; 32: 547-51.
16. ESR Communicable Disease Centre. Surveillance and control notes. NZ Public Health Rep 1996; 3: 20-1.
17. Mandell GL, Kaye D, Levison ME, Hook EW. Enterococcal endocarditis. Arch Intern Med 1970; 125: 258-64.
18. Henry NK, Wllson WR, Geraci JE. Treatment of streptomycin-susceptible enterococcal experimental endocarditis with combinations of penicillin and low-or high-dose streptomycin. Antimicrob Agents Chemother 1986; 30: 725-8.
19. Mederski-Samoraj BD, Murray BE. High-level resistance to gentamicin in clinical isolates of enterococci. J Infect Dis 1983; 147: 751-7.
20. Zervos MJ, Kauffman CA, Therasse PM, Bergman AG, Mikesell TS, Schaberg DR. Nosocomial infection by gentamicin-resistant Streptococcus faecalis: an epidemiologic study. Ann Intern Med 1987; 106: 687-91.
21. Vandamme P, Vercauteren E, Lammens C, et al. Survey of enterococcal susceptibility patterns in Belgium. J Clin Microbiol 1996; 34: 2572-6.
22. Pompei R, Lampis G, Berutti F, Thaller M. Characterization of yellow-pigmented enterococci from severe human infections. J Clin Microbiol 1991; 29: 2884-6.
23. Ruoff KL, De la Maza L, Murtagh MJ, Spargo JD, Ferraro MJ. Species identities of enterococci isolated from clinical specimens. J Clin Microbiol 1990; 28: 435-7.
24. Frieden TR, Munsiff SS, Low DE, et al. Emergence of vancomycin-resistant enterococci in New York City. Lancet 1993; 342: 76-9.
25. Jordens JZ, Bates J, Griffiths DT. Faecal carriage and nosocomial spread of vancomycin-resistant E. faecium. J Antimicrob Chemother 1994; 34: 515-28.
26. Bates J, Jordens JZ, Griffiths DT. Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. J Antimicrob Chemother 1994; 34: 507-16.
27. Donnely JP, Voss A, Witte W, Murray BE. Does the use in animals of antimicrobial agents, including glycopeptide antibiotics, influence the efficacy of antimicrobial therapy in humans? J Antimicrobial Chemother 1996; 37: 389-90.
28. Noble WC, Virani Z, Cree RGA. Co-transfer of vancomycin and other resistant genes from Enterococcus faecalis to Staphylococcus aureus. FEMS Microbiol Lett 1992; 93: 195-8.